Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Pipette Management Tool

November 16, 2011 7:23 am | Product Releases | Comments

Integra has announced Vialink - a pipette management tool that allows users to simply create and manage custom programs, maintain a service history, and transfer firmware upgrade details between Viaflo electronic pipettes and your PC.


FDA Purchases FlowCAM System

November 16, 2011 7:16 am | News | Comments

The U.S. Food and Drug Administration has purchased the FlowCAM particle imaging and analysis system from laboratory instrumentation manufacturer Fluid Imaging Technologies.


Researchers Discover Regulator of Human Cell Activity

November 16, 2011 6:51 am | News | Comments

Research teams have discovered that the SHARPIN protein regulates human cell activity. Recent study concludes that SHARPIN regulates the movement and activity of inflammatory cells and of lung and prostate cancer cells.


Pantarhei Publishes ZP3 Cancer Strategy

November 16, 2011 6:46 am | News | Comments

Pantarhei Bioscience announces the publication of the results of an innovative treatment strategy for ovarian cancer. Pantarhei Bioscience is developing the zona pellucida protein 3 antigen as immunisation strategy against ovarian cancer.


Government Funding New TB Trials

November 16, 2011 6:40 am | News | Comments

The TB Alliance announces the launch of a collaboration with the National Institute of Allergy and Infectious Diseases’ AIDS Clinical Trial Group to conduct and help complete a Phase 3 clinical trial testing potentially faster-acting tuberculosis treatments.


Amarin Announces ANCHOR Data

November 16, 2011 6:31 am | News | Comments

Amarin Corporation plc announced data from its Phase 3 clinical trial that showed patients with high triglycerides who were also on statin therapy experienced a significant reduction in triglyceride levels and other lipid parameters.


Gilead-J & J Working on HIV Pill

November 16, 2011 6:26 am | News | Comments

Gilead Sciences Inc. and Johnson & Johnson's Tibotec unit said they will collaborate to develop a new HIV pill that combines Tibotec's Prezista with Gilead's drug Emtriva and two experimental drugs.


Geron Halts Stem Cell Study

November 16, 2011 6:00 am | News | Comments

Geron Corp. is exiting the field it pioneered in a calculated business move that underscores the long, costly path embryonic stem cells face to become real-world products.


Fastest Campus Supercomputer Studies Stem Cells

November 15, 2011 11:34 am | News | Comments

The nation's fastest campus supercomputer, built at Purdue University, is being used for a variety of research projects, including cancer stem cell studies.

NIH Launches Rare Disease Drug Development Projects

November 15, 2011 11:31 am | News | Comments

Researchers will begin drug development projects for rare and neglected diseases that include potential treatments for a musculoskeletal disorder.


Trial Approved for Insulin-Coated Gold Nanoparticle

November 15, 2011 11:28 am | News | Comments

Midatech received Swissmedic approval to start a clinical trial with insulin-coated gold nanoparticles.


Anavex Completes Phase 1 Alzheimer’s Trial

November 15, 2011 11:22 am | News | Comments

Anavex Life Sciences announced the completion of its Phase 1 single ascending dose clinical trial of Anavex 2-73, the company’s lead drug candidate for the treatment of Alzheimer’s.


Abbott Comments on Aim-High Study Results

November 15, 2011 11:20 am | News | Comments

Abbott’s National Heart, Lung and Blood Institute reported its final results for its Aim-High study.

Concert Pharmaceuticals, NIH Research Collaborate

November 15, 2011 11:15 am | News | Comments

Concert Pharmaceuticals Inc. has entered a research collaboration with The National Institutes of Health Therapeutics for Rare and Neglected Diseases program.


Biosensor Built from Carbon Nanotubes, DNA

November 15, 2011 11:06 am | News | Comments

Purdue University scientists have developed a method for stacking synthetic DNA and carbon nanotubes onto a biosensor electrode.


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.